CRISPR Therapeutics AG CRSP
883 filings, 14 in the last 30 days
SEC filing indexWhat the 8-Ks said
1 event in the last 3 years: the officer, auditor, restatement, cyber, restructuring, listing, impairment and debt items. One line each, the filing's own words.
- Oct 19, 2026 CEO, CFO, COO or CAOCFO change “Silver’s appointment to the position of Chief Financial Officer, the Company’s wholly owned subsidiary, CRISPR Therapeutics, Inc (“CRISPR Inc.”), entered into an Employment Agreement with Mr.” 8-K item 5.02 · all documents
From the SEC filing index and the text of each 8-K. A line appears only when the 8-K names one of these items; for item 5.02 only a move of the CEO, CFO, COO or chief accounting officer. Older 8-Ks may have no text downloaded, so they show no quote.
Late filings, 8-K notices and going concern
None found in the last 2 years
-
Late filing notices (NT 10-K, NT 10-Q)No notice in the last 2 years.
-
8-K notices: listing, impairment, debt triggerNo item 3.01, 2.06 or 2.04 in the last 2 years.
-
Going-concern language in the 10-KNo statement of substantial doubt in the latest 10-K.
Facts to read in the filing, not a verdict: many companies with one of these carry on normally, and a company with neither can still have problems.
Every filing on one line
Each mark is a filing or an event in one; the bigger square is a 10-K. Hover for what it is, click to open it.
All 47 events
- Nov 6, 2026 Planned sale RAJU PRASAD (Officer) gave notice of a planned sale of 79,393 shares worth about $4.0MForm 144, approximate sale date Nov 6, 2026
- Nov 2, 2026 8-K Quarterly results8-K item 2.02
- Nov 2, 2026 10-Q Quarterly report (10-Q)period ended Sep 30, 2026
- Oct 19, 2026 Officer CFO changeSilver’s appointment to the position of Chief Financial Officer, the Company’s wholly owned subsidiary, CRISPR Therapeutics, Inc (“CRISPR Inc.”), entered into an Employment Agreement with Mr.
- Oct 14, 2026 Planned sale SIMEON GEORGE (Director) gave notice of a planned sale of 14,514 shares worth about $720KForm 144, approximate sale date Oct 14, 2026
- Oct 6, 2026 Planned sale JAMES KASINGER (Officer) gave notice of a planned sale of 1,990 shares worth about $119KForm 144, approximate sale date Oct 6, 2026, under a 10b5-1 plan adopted May 6, 2026
- Sep 22, 2026 Planned sale JAMES KASINGER (Officer) gave notice of a planned sale of 10,400 shares worth about $626KForm 144, approximate sale date Sep 22, 2026, under a 10b5-1 plan adopted May 6, 2026
- Sep 17, 2026 Planned sale ALI BEHBAHANI (Director) gave notice of a planned sale of 13,679 shares worth about $781KForm 144, approximate sale date Sep 17, 2026
- Aug 3, 2026 Planned sale James R. Kasinger (General Counsel and Secretary) adopted a 10b5-1 trading planreported in the 10-Q, up to 93,632 shares, runs to May 31, 2027
- Aug 3, 2026 Planned sale Raju Prasad (Chief Financial Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 14,565 shares, runs to May 31, 2027
- Aug 3, 2026 8-K Quarterly results8-K item 2.02
- Aug 3, 2026 10-Q Quarterly report (10-Q)period ended Jun 30, 2026
- Jun 4, 2026 8-K Director or officer change, Bylaws or fiscal year changed, Shareholder vote results8-K items 5.02, 5.03, 5.07
- May 4, 2026 8-K Quarterly results8-K item 2.02
- May 4, 2026 10-Q Quarterly report (10-Q)period ended Mar 31, 2026
- Mar 16, 2026 8-K Material agreement signed, New debt or obligation, Unregistered share sale8-K items 1.01, 2.03, 3.02
- Mar 11, 2026 8-K Other events8-K item 8.01
- Feb 12, 2026 Planned sale Katherine A. High (M.D. (Member of the Board of Directors)) adopted a 10b5-1 trading planreported in the 10-K, up to 22,000 shares, runs to Mar 12, 2027
- Feb 12, 2026 Planned sale Simeon J. George (M.D. (Member of the Board of Directors)) adopted a 10b5-1 trading planreported in the 10-K, up to 116,000 shares, runs to Apr 13, 2027
- Feb 12, 2026 Planned sale Naimish Patel (M.D. (Chief Medical Officer)) adopted a 10b5-1 trading planreported in the 10-K, up to 6,068 shares, runs to Dec 31, 2026
- Feb 12, 2026 8-K Quarterly results8-K item 2.02
- Feb 12, 2026 10-K Annual report (10-K)period ended Dec 31, 2025
- Jan 22, 2026 Planned sale RAJU PRASAD (Officer) gave notice of a planned sale of 34,972 shares worth about $2.1MForm 144, approximate sale date Jan 22, 2026, under a 10b5-1 plan adopted Aug 18, 2025
- Jan 22, 2026 Planned sale Samarth Kulkarni (Officer) gave notice of a planned sale of 60,000 shares worth about $3.6MForm 144, approximate sale date Jan 22, 2026, under a 10b5-1 plan adopted Aug 27, 2025
- Jan 20, 2026 Planned sale Samarth Kulkarni (Officer) gave notice of a planned sale of 30,000 shares worth about $1.6MForm 144, approximate sale date Jan 20, 2026, under a 10b5-1 plan adopted Aug 27, 2025
- Jan 12, 2026 8-K Other events8-K item 8.01
- Jan 6, 2026 Planned sale RAJU PRASAD (Officer) gave notice of a planned sale of 29,700 shares worth about $1.8MForm 144, approximate sale date Jan 6, 2026, under a 10b5-1 plan adopted Aug 18, 2025
- Dec 22, 2025 Planned sale RAJU PRASAD (Officer) gave notice of a planned sale of 10,000 shares worth about $560KForm 144, approximate sale date Dec 22, 2025, under a 10b5-1 plan adopted Aug 18, 2025
- Nov 10, 2025 Planned sale James R. Kasinger (General Counsel) adopted a 10b5-1 trading planreported in the 10-Q, up to 93,632 shares, runs to Jun 30, 2026
- Nov 10, 2025 Planned sale Raju Prasad, (Chief Financial Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 74,672 shares, runs to Jun 22, 2026
- Nov 10, 2025 Planned sale Samarth Kulkarni (Chief Executive Officer) ended a 10b5-1 trading planreported in the 10-Q, up to 75,000 shares, runs to Jun 30, 2026
- Nov 10, 2025 8-K Quarterly results8-K item 2.02
- Nov 10, 2025 10-Q Quarterly report (10-Q)period ended Sep 30, 2025
- Oct 15, 2025 Offering At-the-market program: up to $600M of common stock424B5 · In accordance with the terms of the Sales Agreement, under this prospectus supplement we may offer and sell our common shares, CHF 0.03 nominal value, having an aggregate offering price of up to $600,000,000 from time to time through Jefferies, acting as our agent.
- Oct 15, 2025 8-K Other events8-K item 8.01
- Aug 4, 2025 Planned sale Samarth Kulkarni (Chief Executive Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 75,000 shares
- Aug 4, 2025 8-K Quarterly results8-K item 2.02
- Aug 4, 2025 10-Q Quarterly report (10-Q)period ended Jun 30, 2025
- Jun 26, 2025 8-K Other events8-K item 8.01
- Jun 9, 2025 8-K Bylaws or fiscal year changed, Shareholder vote results8-K items 5.03, 5.07
- May 19, 2025 Offering Sale of 1.8M new shares424B5 · We are offering an aggregate of 1,842,105 of our common shares, or the Shares, directly to Sirius Therapeutics, or Sirius, pursuant to a Share Issuance Agreement, dated May 19, 2025, or the Share Issuance Agreement, in connection with a Collaboration, Option and License Agreement, dated May 19, 2025
- May 19, 2025 8-K Material agreement signed, Other events8-K items 1.01, 8.01
- May 6, 2025 8-K Quarterly results8-K item 2.02
- May 6, 2025 10-Q Quarterly report (10-Q)period ended Mar 31, 2025
- Mar 26, 2025 8-K Director or officer change8-K item 5.02
- Feb 11, 2025 8-K Quarterly results8-K item 2.02
- Feb 11, 2025 10-K Annual report (10-K)period ended Dec 31, 2024
From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).
Every filing
Newest first, by kind · each form links to sec.gov
| Filed | Form | What it is |
|---|---|---|
| Nov 13, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Nov 6, 2026 | 144 | Notice of planned insider sale |
| Nov 6, 2026 | 4 | Insider trade |
| Nov 2, 2026 | 3 | New insider |
| Nov 2, 2026 | 10-Q | Quarterly report |
| Nov 2, 2026 | 8-K | Quarterly results |
| Oct 28, 2026 | 4 | Insider trade |
| Oct 28, 2026 | 4 | Insider trade |
| Oct 28, 2026 | 4 | Insider trade |
| Oct 28, 2026 | 4 | Insider trade |
| Oct 21, 2026 | 4 | Insider trade |
| Oct 21, 2026 | 3 | New insider |
| Oct 20, 2026 | 4 | Insider trade |
| Oct 19, 2026 | 8-K | Director or officer change |
| Oct 16, 2026 | 4 | Insider trade |
| Oct 15, 2026 | 4 | Insider trade |
| Oct 15, 2026 | 4 | Insider trade |
| Oct 14, 2026 | 144 | Notice of planned insider sale |
| Oct 8, 2026 | 4 | Insider trade |
| Oct 6, 2026 | 144 | Notice of planned insider sale |
| Sep 24, 2026 | 4 | Insider trade |
| Sep 22, 2026 | 144 | Notice of planned insider sale |
| Sep 21, 2026 | 4 | Insider trade |
| Sep 21, 2026 | 4 | Insider trade |
| Sep 17, 2026 | 144 | Notice of planned insider sale |
| Aug 14, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Aug 11, 2026 | 4 | Insider trade |
| Aug 3, 2026 | 10-Q | Quarterly report |
| Aug 3, 2026 | 8-K | Quarterly results |
| Jul 27, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Jun 9, 2026 | 4 | Insider trade |
| Jun 9, 2026 | 4 | Insider trade |
| Jun 9, 2026 | 4 | Insider trade |
| Jun 9, 2026 | 4 | Insider trade |
| Jun 9, 2026 | 4 | Insider trade |
| Jun 9, 2026 | 4 | Insider trade |
| Jun 9, 2026 | 4 | Insider trade |
| Jun 9, 2026 | 4 | Insider trade |
| Jun 9, 2026 | 4 | Insider trade |
| Jun 9, 2026 | 4 | Insider trade |
| Jun 5, 2026 | S-8 | Shares registered for employee plans |
| Jun 4, 2026 | 8-K | Director or officer change, Bylaws or fiscal year changed, Shareholder vote results |
| Jun 2, 2026 | 4 | Insider trade |
| Jun 2, 2026 | 4 | Insider trade |
| Jun 2, 2026 | 4 | Insider trade |
| Jun 1, 2026 | 4 | Insider trade |
| May 15, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| May 14, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| May 4, 2026 | 10-Q | Quarterly report |
| May 4, 2026 | 8-K | Quarterly results |
| Apr 30, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Apr 21, 2026 | ARS | Annual report to shareholders |
| Apr 21, 2026 | DEFA14A | Extra proxy material |
| Apr 21, 2026 | DEF 14A | Proxy statement |
| Apr 2, 2026 | PRE 14A | |
| Mar 24, 2026 | 4 | Insider trade |
| Mar 24, 2026 | 4 | Insider trade |
| Mar 24, 2026 | 4 | Insider trade |
| Mar 24, 2026 | 4 | Insider trade |
| Mar 17, 2026 | 4 | Insider trade |
| Mar 17, 2026 | 4 | Insider trade |
| Mar 17, 2026 | 4 | Insider trade |
| Mar 17, 2026 | 4 | Insider trade |
| Mar 16, 2026 | 8-K | Material agreement signed, New debt or obligation, Unregistered share sale |
| Mar 12, 2026 | 4 | Insider trade |
| Mar 12, 2026 | 4 | Insider trade |
| Mar 11, 2026 | 8-K | Other events |
| Feb 20, 2026 | 4 | Insider trade |
| Feb 20, 2026 | 4 | Insider trade |
| Feb 17, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Feb 12, 2026 | 10-K | Annual report |
| Feb 12, 2026 | 8-K | Quarterly results |
| Feb 5, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Jan 27, 2026 | 4 | Insider trade |
| Jan 26, 2026 | 4 | Insider trade |
| Jan 22, 2026 | 144 | Notice of planned insider sale |
| Jan 22, 2026 | 144 | Notice of planned insider sale |
| Jan 22, 2026 | 4 | Insider trade |
| Jan 20, 2026 | 144 | Notice of planned insider sale |
| Jan 12, 2026 | 8-K | Other events |
| Jan 8, 2026 | 4 | Insider trade |
| Jan 6, 2026 | 144 | Notice of planned insider sale |
| Dec 23, 2025 | 4 | Insider trade |
| Dec 22, 2025 | 144 | Notice of planned insider sale |
| Dec 22, 2025 | 4 | Insider trade |
| Nov 14, 2025 | SCHEDULE 13G | 5%+ owner (passive) |
| Nov 10, 2025 | 10-Q | Quarterly report |
| Nov 10, 2025 | 8-K | Quarterly results |
| Nov 4, 2025 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Oct 20, 2025 | 4 | Insider trade |
| Oct 15, 2025 | 4 | Insider trade |
| Oct 15, 2025 | 4 | Insider trade |
| Oct 15, 2025 | 8-K | Other events |
| Oct 15, 2025 | 424B5 | Prospectus |
| Oct 3, 2025 | 4 | Insider trade |
| Oct 3, 2025 | 4 | Insider trade |
| Oct 3, 2025 | 4 | Insider trade |
| Oct 3, 2025 | 4 | Insider trade |
| Sep 19, 2025 | 4 | Insider trade |
| Aug 19, 2025 | 4 | Insider trade |
Show the other 75 filings on this page
Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.
Sources
SEC's filing index (data.sec.gov submissions). Each form links to the document on sec.gov.
Also
Earnings releases: the text of each quarter's results release. Statements by period: the income statement, balance sheet or cash flow of the last filings side by side.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/CRSP/export.csv") into a cell.